Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Patten

Showing results (231-240 of 237) with videos related to

Pageof 24
Sort By:
You have reached the last page of results.This site can display upto 237 results.
The New England Journal of Medicine|June 16, 2025
Measurable Residual Disease-Guided Therapy for Chronic Lymphocytic LeukemiaTalha Munir, Sean Girvan, David A Cairns, et al.
British Journal of Haematology|April 29, 2022
A national service for delivering CD19 CAR-Tin large B-cell lymphoma - The UK real-world experienceAndrea Kuhnl, Claire Roddie, Amy A Kirkwood, et al.
Nature Medicine|December 18, 2021
Tisagenlecleucel in adult relapsed or refractory follicular lymphoma: the phase 2 ELARA trialNathan Hale Fowler, Michael Dickinson, Martin Dreyling, et al.
Blood|January 9, 2024
Durable response after tisagenlecleucel in adults with relapsed/refractory follicular lymphoma: ELARA trial updateMartin Dreyling, Nathan Hale Fowler, Michael Dickinson, et al.
Cancer Cell|January 21, 2021
Acute Immune Signatures and Their Legacies in Severe Acute Respiratory Syndrome Coronavirus-2 Infected Cancer PatientsSultan Abdul-Jawad, Luca Baù, Thanussuyah Alaguthurai, et al.
Blood|July 23, 2021
COVID-19 in patients with CLL: improved survival outcomes and update on management strategiesLindsey E Roeker, Toby A Eyre, Meghan C Thompson, et al.
Blood|July 21, 2020
Outcomes of COVID-19 in patients with CLL: a multicenter international experienceAnthony R Mato, Lindsey E Roeker, Nicole Lamanna, et al.
Pageof 24

Showing results (231-240 of 237) with videos related to

Sort By:
Pageof 24
You have reached the last page of results.This site can display upto 237 results.
The New England Journal of Medicine|June 16, 2025
Measurable Residual Disease-Guided Therapy for Chronic Lymphocytic LeukemiaTalha Munir, Sean Girvan, David A Cairns, et al.
British Journal of Haematology|April 29, 2022
A national service for delivering CD19 CAR-Tin large B-cell lymphoma - The UK real-world experienceAndrea Kuhnl, Claire Roddie, Amy A Kirkwood, et al.
Nature Medicine|December 18, 2021
Tisagenlecleucel in adult relapsed or refractory follicular lymphoma: the phase 2 ELARA trialNathan Hale Fowler, Michael Dickinson, Martin Dreyling, et al.
Blood|January 9, 2024
Durable response after tisagenlecleucel in adults with relapsed/refractory follicular lymphoma: ELARA trial updateMartin Dreyling, Nathan Hale Fowler, Michael Dickinson, et al.
Cancer Cell|January 21, 2021
Acute Immune Signatures and Their Legacies in Severe Acute Respiratory Syndrome Coronavirus-2 Infected Cancer PatientsSultan Abdul-Jawad, Luca Baù, Thanussuyah Alaguthurai, et al.
Blood|July 23, 2021
COVID-19 in patients with CLL: improved survival outcomes and update on management strategiesLindsey E Roeker, Toby A Eyre, Meghan C Thompson, et al.
Blood|July 21, 2020
Outcomes of COVID-19 in patients with CLL: a multicenter international experienceAnthony R Mato, Lindsey E Roeker, Nicole Lamanna, et al.
Pageof 24